BENEFIT OF ADD ON LOW DOSE ORAL TOLVAPTAN TO LOOP DIURETICS IN ACUTE DECOMPENSATED HEART FAILURE PATIENTS: A RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Chitthai, Ratthaphon [1 ,2 ]
Saisa-Ard, Jingjo [1 ,2 ]
Inkong, Pitchamon [1 ,2 ]
Chaiprasert, Amnart [1 ,2 ]
Nata, Naowanit [1 ,2 ]
Tasanavipas, Pamila [1 ,2 ]
Varothai, Narittaya [1 ,2 ]
Thimachai, Paramat [1 ,2 ]
Supasyndh, Ouppatham [1 ,2 ]
Satirapoj, Bancha [1 ,2 ]
机构：
[1] Phramongkutklao Hosp & Coll Med, Div Nephrol, Dept Med, Bangkok, Thailand
[2] Phramongkutklao Hosp & Coll Med, Div Cardiol, Dept Med, Bangkok, Thailand
来源：
NEPHROLOGY | 2021年 / 26卷
关键词：
Tolvaptan; acute decompensated heart failure; ADHF score; body weight; plasma sodium;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P066
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [21] The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge
    Matsumoto, Kenji
    Ehara, Shoichi
    Nakamura, Yasuhiro
    Otsuka, Keiko
    Kawase, Yoshio
    HEART AND VESSELS, 2018, 33 (10) : 1204 - 1213
  • [22] The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge
    Kenji Matsumoto
    Shoichi Ehara
    Yasuhiro Nakamura
    Keiko Otsuka
    Yoshio Kawase
    Heart and Vessels, 2018, 33 : 1204 - 1213
  • [23] A randomized, controlled trial of the renal effects of ultratiltration as compared to furosemide in patients with acute decompensated heart failure
    Rogers, Hobart L.
    Marshall, Joanne
    Bock, Jeremy
    Dowling, Thomas C.
    Feller, Erika
    Robinson, Shawn
    Gottlieb, Stephen S.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (01) : 1 - 5
  • [24] Prediction of acute effect on urine output of a novel diuretics tolvaptan in patients with decompensated heart falure
    Fukunami, M.
    Hori, M.
    Matsuzaki, M.
    Izumi, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S246 - S246
  • [25] Voluminous Responses to Loop Diuretics Are Safe in Patients With Acute Decompensated Heart Failure and Chronic Kidney Disease
    Sunkara, Bipin
    Dorsch, Michael P.
    Nicklas, J. Matthew
    Nicklas, John M.
    CIRCULATION, 2018, 138
  • [26] Efficacy and safety of intravenous versus oral tolvaptan in the acute phase of acute decompensated heart failure
    Okada, Tomoaki
    Takagi, Wataru
    Miyoshi, Toru
    Oka, Akihiro
    Seiyama, Kosuke
    Ugawa, Satoko
    Nosaka, Kazumasa
    Doi, Masayuki
    JOURNAL OF CARDIOLOGY, 2025, 85 (01) : 38 - 39
  • [27] Loop diuretic strategies in patients with acute decompensated heart failure: A meta-analysis of randomized controlled trials
    Wu, Mei-Yi
    Chang, Nen-Chung
    Su, Chien-Ling
    Hsu, Yung-Ho
    Chen, Tzen-Wen
    Lin, Yuh-Feng
    Wu, Chih-Hsiung
    Tam, Ka-Wai
    JOURNAL OF CRITICAL CARE, 2014, 29 (01) : 2 - 9
  • [28] Ultra-High Dose Infusions of Loop Diuretics Are Effective and Safe in Patients With Acute Decompensated Heart Failure and Chronic Kidney Disease
    Sunkara, Bipin
    Dorsch, Michale
    Nicklas, John M.
    CIRCULATION, 2018, 138
  • [29] Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure
    Carles Trullas, Joan
    Luis Morales-Rull, Jose
    Casado, Jesus
    Freitas Ramirez, Adriana
    Manzano, Luis
    Formiga, Francesc
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (07) : 529 - 536
  • [30] MIXED TREATMENT ANALYSIS OF TOLVAPTAN, ULTRAFILTRATION AND LOOP DIURETICS IN THE MANAGEMENT OF ACUTE CONGESTIVE HEART FAILURE
    Dayanand, S.
    Martinez, J. M.
    Chait, R.
    CARDIOLOGY, 2016, 134 : 429 - 429
12345